Effect of Mipomersen in Severe Hypercholesterolemia Version 1.0

• Research type

  Research Study

• Full title

  A Prospective Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen in Patients with Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and who are not on Apheresis

• IRAS ID

  14935

• Contact name

  Gordon Ferns

• Contact email

  G.Ferns@surrey.ac.uk

• Sponsor organisation

  Genzyme Corporation

• Eudract number

  2008-006020-53

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  NCT00794664

• Research summary

  Research Summary not published at request of researcher

• REC name

  London - Dulwich Research Ethics Committee

• REC reference

  09/H0808/12

• Date of REC Opinion

  17 Apr 2009

• REC opinion

  Further Information Favourable Opinion